FDA Inspection 1238053 — US Naval Hospital Okinawa
The FDA completed an inspection of US Naval Hospital Okinawa on Apr 23, 2024 in Ginowan City (Okinawa). The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 23, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ginowan City (Okinawa) (Japan)